.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Fairwinds is stocked at 208 licensed dispensaries across Washington, with the deepest coverage in Seattle, Spokane, Tacoma, Vancouver, and Everett. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Fairwinds finished September 2026 with a concentrated category mix: Tincture & Sublingual held 46.57% share but declined 15.78% year over year and 8.33% month over month, while Vapor Pens reached 25.15% share with 11.85% YoY growth and 6.17% MoM growth. Capsules accounted for 14.93% share with a 13.49% YoY decline offset by a 14.76% MoM gain, and Topical held 11.77% share with a 9.75% YoY decline and 2.81% MoM dip. Small tails were volatile: Flower at 0.71% share surged 89.77% MoM after a 67.36% YoY drop, Concentrates at 0.87% share fell 26.25% MoM and 50.55% YoY, and Pre-Roll at 0.01% share contracted 41.71% MoM and 78.42% YoY. The pattern implies Fairwinds is leaning further into wellness-led formats while the core Tincture & Sublingual headwind pulls overall sales down 10.76% YoY despite MoM stabilization in growth categories.
With Tincture & Sublingual ranked 2 in Washington and still nearly half of sales, the 8.33% MoM contraction alongside a 6.17% MoM lift in Vapor Pens and a 14.76% MoM lift in Capsules suggests a shift toward faster-turn inhalable and dose-controlled options at a nearly flat average price mix (+1.79% YoY brandwide). The double-digit YoY declines in Capsules (-13.49%) and Topical (-9.75%) paired with a positive YoY in Vapor Pens (+11.85%) indicate reliance on one growing adjacency while legacy wellness formats cycle down; this positioning implies Fairwinds must either defend Tincture & Sublingual share at rank 2 or accelerate the pivot into Vapor Pens to offset a 29.69% two-year contraction.
Competitive Landscape
Fairwinds is ranked #2 in Washington Tincture & Sublingual in September 2026, unchanged from #2 year over year, and it held #2 across the last three months while peaking at #1 in July 2026; against this steady position, Green Revolution sits at #1 with no YoY rank change and declining sales of 5.8%, and HiKu improved from #4 to #3 with 9.0% YoY sales growth. Meanwhile, Ceres slipped from #3 to #4 with a 34.5% YoY sales decline while Canna Cantina held #5 with a 10.5% YoY decline, indicating that Fairwinds’ flat rank coupled with peers’ mixed momentum suggests a stable but contested hold on the #2 spot and a pathway to reclaim #1 if it converts July 2026’s peak into sustained share gains.
Notable Products
CBD/THC 5:1 Companion Savory Bacon 64x Tincture (200mg CBD, 40mg THC, 8ml, 0.54 fl oz) led September 2026 despite a -7.9% MoM decline and held rank 1, while CBD/CBN/THC 5:5:1 Deep Sleep Tincture (250mg CBD, 250mg CBN, 50mg THC, 0.45 fl oz) slipped a marginal -0.02% MoM yet stayed at rank 2; in contrast, the smaller CBD/THC 5:1 Companion Savory Bacon 32x Tincture (100mg CBD, 20mg THC, 0.27 fl oz, 8ml) rose +1.6% MoM and maintained rank 3. Four of the top ten are Tincture & Sublingual SKUs, and Vapor Pens occupy ranks 6, 8, 9, and 10 with MoM moves of -1.9%, null, null, and -1.1%, signaling category breadth even as Topical fell -8.4% at rank 7. With the top SKU generating $24,778 and the 1:1 Ratio Tincture at rank 5 growing +4.7% MoM, the mix tilts toward multi-cannabinoid tinctures that can absorb softening in Topical and stabilize share against variability in Vapor Pens. The pattern implies Fairwinds is consolidating leadership around ratio-driven tinctures while using cartridges for reach, which points to a strategy prioritizing consistent, higher-ranked wellness formats over more volatile ancillary categories.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
